Iterum Therapeutics Plc Accounts Payable

Iterum Therapeutics Plc (ITRM) currently reports a accounts payable of $580K as of September 2025. That compares with $840K in the prior-year period — down 30.9% year over year. Use the charts on this page to explore Iterum Therapeutics Plc's accounts payable history and peer comparisons.

Iterum Therapeutics Plc's accounts payable decreased from $840K to $580K — a 30.9% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Iterum Therapeutics Plc reported $580K in accounts payable as of September 2025. That compares with $840K in the prior-year period — down 30.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $580K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Iterum Therapeutics Plc, and consider following ITRM for alerts when major investors trade the stock.

Iterum Therapeutics Plc is classified in the Healthcare sector. On accounts payable, it currently shows $580K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ITRM with unrelated industries.